| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
23,910,000 |
| Market
Cap: |
2.39(B) |
| Last
Volume: |
165,174 |
Avg
Vol: |
186,425 |
| 52
Week Range: |
$81.08 - $209.15 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 789 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile ICU Medical is an infusion therapy company. Co. has four product lines: Infusion Consumables, which include Clave™ needlefree products, SwabCap and SwabTip disinfecting caps, ClearGuard HD antimicrobial barrier caps for hemodialysis catheters and Tego™ hemodialysis connector used to cap and protect hemodialysis central venous catheter hubs; Infusion Systems, which provide infusion pumps, dedicated IV sets, software and other services; IV Solutions, which provide a supply of IV solutions, irrigation and nutritionals; and Critical Care, which helps clinicians get real-time access to patients' hemodynamic and cardiac status with a portfolio of monitoring systems and sensors and catheters.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
25,835 |
| Total Buy Value |
$0 |
$0 |
$0 |
$4,467,256 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
1,731,983 |
1,733,712 |
1,800,756 |
1,804,487 |
| Total Sell Value |
$183,670,269 |
$183,822,465 |
$195,804,141 |
$196,491,165 |
| Total People Sold |
6 |
6 |
8 |
8 |
| Total Sell Transactions |
12 |
13 |
17 |
23 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2022-03-06 |
4 |
D |
$0.00 |
$155,232 |
D/D |
(1,267) |
9,757 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2022-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,862 |
10,385 |
|
- |
|
| Mcgrody Kevin J |
Chief Accounting Officer |
• – – |
2022-03-06 |
4 |
D |
$242.93 |
$242,444 |
D/D |
(998) |
4,447 |
|
- |
|
| Mcgrody Kevin J |
Chief Accounting Officer |
• – – |
2022-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,897 |
4,913 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2022-03-06 |
4 |
D |
$242.93 |
$388,445 |
D/D |
(1,599) |
3,045 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2022-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,039 |
3,884 |
|
- |
|
| Bonnell Brian Michael |
Chief Financial Officer |
• – – |
2022-03-06 |
4 |
D |
$242.93 |
$290,544 |
D/D |
(1,196) |
4,431 |
|
- |
|
| Bonnell Brian Michael |
Chief Financial Officer |
• – – |
2022-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,273 |
5,247 |
|
- |
|
| Voigtlander Christian B. |
Chief Operating Officer |
• – – |
2022-03-06 |
4 |
D |
$242.93 |
$382,858 |
D/D |
(1,576) |
12,469 |
|
- |
|
| Voigtlander Christian B. |
Chief Operating Officer |
• – – |
2022-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,995 |
13,285 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2022-03-06 |
4 |
D |
$242.93 |
$411,038 |
D/D |
(1,692) |
14,303 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2022-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,216 |
15,063 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2022-03-03 |
4 |
AS |
$240.00 |
$8,640,000 |
D/D |
(36,000) |
12,779 |
|
-32% |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2022-03-03 |
4 |
OE |
$58.79 |
$2,116,440 |
D/D |
36,000 |
48,779 |
|
- |
|
| Smiths Group Plc |
10% Owner |
– – • |
2022-01-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,500,000 |
|
-19% |
|
| Smiths Group International Holdings Ltd |
10% Owner |
– – • |
2022-01-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,500,000 |
|
-19% |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2021-12-30 |
4 |
AS |
$240.00 |
$278,160 |
D/D |
(1,159) |
12,779 |
|
-23% |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2021-12-30 |
4 |
OE |
$58.79 |
$68,138 |
D/D |
1,159 |
13,938 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2021-12-29 |
4 |
AS |
$240.00 |
$2,562,493 |
D/D |
(10,677) |
12,779 |
|
-16% |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2021-12-29 |
4 |
OE |
$58.79 |
$627,701 |
D/D |
10,677 |
23,456 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2021-12-28 |
4 |
AS |
$240.00 |
$39,360 |
D/D |
(164) |
12,779 |
|
-13% |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2021-12-28 |
4 |
OE |
$58.79 |
$9,642 |
D/D |
164 |
12,943 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2021-11-03 |
4 |
AS |
$240.00 |
$5,760,046 |
D/D |
(24,000) |
12,779 |
|
2% |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2021-11-03 |
4 |
OE |
$58.79 |
$1,410,960 |
D/D |
24,000 |
24,779 |
|
- |
|
| Swinney Robert S |
Director |
– • – |
2021-09-15 |
4 |
S |
$243.00 |
$524,151 |
D/D |
(2,157) |
20,816 |
|
14% |
|
1476 Records found
|
|
Page 6 of 60 |
|
|
0.95 (0.96%) 
